Cite
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients
MLA
Enzo Ricci, et al. “Potential Therapeutic Targets for ALS: MIR206, MIR208b and MIR499 Are Modulated during Disease Progression in the Skeletal Muscle of Patients.” Scientific Reports, vol. 7, Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5d340e137eca6f8dacf5a25253b1ba00&authtype=sso&custid=ns315887.
APA
Enzo Ricci, Mario Sabatelli, Amelia Conte, Lorena Di Pietro, Wanda Lattanzi, Giorgio Tasca, Mauro Monforte, Maria Grazia Berardinelli, Giandomenico Logroscino, Fabrizio Michetti, Mirko Baranzini, & Camilla Bernardini. (2017). Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Scientific Reports, 7.
Chicago
Enzo Ricci, Mario Sabatelli, Amelia Conte, Lorena Di Pietro, Wanda Lattanzi, Giorgio Tasca, Mauro Monforte, et al. 2017. “Potential Therapeutic Targets for ALS: MIR206, MIR208b and MIR499 Are Modulated during Disease Progression in the Skeletal Muscle of Patients.” Scientific Reports 7 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5d340e137eca6f8dacf5a25253b1ba00&authtype=sso&custid=ns315887.